TT-02332

N/A

Report date: 2024/03/13 15:42:25
NME

Base Information

Drug NameTT-02332
Drug Alias NameTT-02332
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsNerve DegenerationObesityCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTransThera Biosciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTransThera Biosciences Co LtdNeurocrine Biosciences Inc
Inactive CompaniesN/A
Active IndicationsNerve DegenerationObesityCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A